Image

Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants

Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled study is aimed to evaluate the esthetic, clinical, and radiographic outcomes following the placement of immediate single-tooth implant with hard and soft tissue augmentation.

Subjects will randomly assigned to one of two groups:

  • Group A (control group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation only.
  • Group B (study group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation and connective tissue graft (CTG).

The main questions it aims to answer is:

Is there is a significant difference in the esthetic outcome between bone augmentation alone and bone augmentation combined with connective tissue graft after immediate dental implant in the esthetic zone?

Eligibility

Inclusion Criteria:

  • Patients with a non-restorable tooth or a remaining root without signs of acute infection in the maxillary esthetic zone.
  • The failing tooth is an incisor, canine or first bicuspid in the maxilla bounded by natural sound teeth.
  • Sufficient bone (\>4 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥35 N cm).
  • Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration.

Exclusion Criteria:

  • Patients with systemic conditions affecting bone healing (e.g., uncontrolled diabetes).
  • Teeth with current acute periapical infection.
  • Dehiscence of the labial (facial) bone plate after extraction.
  • Signs of uncontrolled periodontal disease.
  • Heavy smokers and vulnerable groups (pregnant females and decision-impaired individuals).
  • History of head and neck radiation therapy.

Study details
    Dental Implant

NCT07333534

University of Baghdad

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.